Summit Therapeutics

Summit Therapeutics EV/FCF

The EV/FCF (Enterprise Value to Free Cash Flow) of Summit Therapeutics (SMMT) as of Nov 22, 2026 is -94.92. In the previous year, EV/FCF (Enterprise Value to Free Cash Flow) was -179.84 — a change of -47.22% (higher).

EV/FCF

-94.92

YoY

-47.22%

Last updated:

EV/FCF (Enterprise Value to Free Cash Flow) of Summit Therapeutics is 2024 -94.92 . EV/FCF (Enterprise Value to Free Cash Flow) of Summit Therapeutics was 2023 -179.84 . It decreases by -47.22% higher compared to the previous year.

The Summit Therapeutics EV/FCF history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EV/FCF
Date
EV/FCF
Jan 1, 2017
-622.29 USD
Jan 1, 2018
-393.49 USD
Jan 1, 2019
-656.39 USD
Jan 1, 2020
-285.33 USD
Jan 1, 2021
-189.87 USD
Jan 1, 2022
-333.63 USD
Jan 1, 2023
-179.84 USD
Jan 1, 2024
-94.92 USD
The Summit Therapeutics EV/FCF history
YEAREV/FCFYoY
-94.92-47.22%
-179.84-46.10%
-333.63+75.71%
-189.87-33.46%
-285.33-56.53%
-656.39+66.81%
-393.49-36.77%
-622.29-153.98%
1,152.82-243.04%
-805.93-34.09%
-1,222.72—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Summit Therapeutics Stock analysis

What does Summit Therapeutics do? Summit Therapeutics Inc. is a global biopharmaceutical company focused on the discovery, development and commercialization of innovative medicines for the treatment of life-threatening and rare diseases. The company is headquartered in Massachusetts, USA and also has offices in Oxford, UK. Summit Therapeutics is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Summit Therapeutics stock

EV/FCF (Enterprise Value to Free Cash Flow) of Summit Therapeutics is -94.92 in 2024.

EV/FCF (Enterprise Value to Free Cash Flow) of Summit Therapeutics changed from -179.84 to -94.92, representing a -47.22% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EV/FCF (Enterprise Value to Free Cash Flow) Summit Therapeutics since 2006 – with annual values, charts, and detailed analysis.

The EV/FCF ratio measures the enterprise value relative to free cash flow. It captures the true cash-generating ability of a business.

To evaluate EV/FCF (Enterprise Value to Free Cash Flow)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/FCF (Enterprise Value to Free Cash Flow).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/FCF (Enterprise Value to Free Cash Flow)'s Summit Therapeutics with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Summit Therapeutics

All Key Metrics — Summit Therapeutics